Plasmapheresis prior to omalizumab administration in a 15-year-old boy with severe asthma and very high IgE levels: sustained effect over 2 years.

Abstract

BACKGROUND Anti-IgE therapy with omalizumab is an innovative therapy option in patients with severe allergic asthma. However, many patients are excluded from this treatment due to very high serum IgE levels which lie above the weight-dependent cut-off for a reasonable omalizumab administration (700 kU/l). OBJECTIVE We sought to evaluate whether a… (More)
DOI: 10.1055/s-0031-1287824

Topics

5 Figures and Tables

Cite this paper

@article{Kerzel2011PlasmapheresisPT, title={Plasmapheresis prior to omalizumab administration in a 15-year-old boy with severe asthma and very high IgE levels: sustained effect over 2 years.}, author={Sebastian Kerzel and Michael Zemlin and Tobias Rogosch and Markus W. Ollert and Huan Renz and G.. Klaus and Rolf Felix Maier}, journal={Klinische Padiatrie}, year={2011}, volume={223 6}, pages={356-9} }